EGFR and non-small cell lung carcinoma: As the proportion of tumor cells in lung tissue samples can vary from 5% to 100% [4], and tumor tissues are often not available from advanced NSCLC for various reasons [7], in which case cytological samples such as plural effusion with low proportion of tumor cells may have to be used as alternatives, more sensitive methods for EGFR mutation testing are warranted.